Cytek Biosciences, Inc. (CTKB) — 10-Q Filings

10-Q Filings (6)

• Cytek Biosciences Swings to Q3 Loss Amid Rising Expenses — Nov 5, 2025 Risk: high
  Cytek Biosciences, Inc. (CTKB) reported a net loss of $5.478 million for the three months ended September 30, 2025, a significant decline from a net income of $
• Cytek Biosciences Q2 Revenue Dips, Swings to Net Loss — Aug 6, 2025 Risk: medium
  Cytek Biosciences, Inc. reported total revenue of $44.2 million for the three months ended June 30, 2025, a decrease from $46.5 million in the prior-year period
• Cytek Biosciences Files Q1 2025 10-Q — May 8, 2025 Risk: low
  Cytek Biosciences, Inc. filed its 10-Q for the period ending March 31, 2025. The company, headquartered in Fremont, CA, reported financial data for the first qu
• Cytek Biosciences Q3 2024 10-Q Filing — Nov 7, 2024 Risk: medium
  Cytek Biosciences, Inc. filed its 10-Q for the period ending September 30, 2024. The company reported financial results for the third quarter and the first nine
• Cytek Biosciences Q2 2024 10-Q Filing — Aug 6, 2024 Risk: medium
  Cytek Biosciences, Inc. filed its 10-Q for the period ending June 30, 2024. The company reported financial results for the second quarter and the first half of
• Cytek Biosciences, Inc. Files 10-Q for Q1 2024 — May 8, 2024 Risk: medium
  Cytek Biosciences, Inc. (CTKB) filed a Quarterly Report (10-Q) with the SEC on May 8, 2024. Revenue for the three months ended March 31, 2024, was $131.5 millio

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX